This study is looking at the effects of suvorexant (belsomra) an insomnia medication that is currently FDA approved and how it interacts/helps people with Bipolar Disorder who are suffering from insomnia. This study can be found on clinicaltrials.gov under the identifier NCT02527564.
Participants can earn up to $175 for completing 6 study visits over the course of 15 weeks (3 weekly visits and 3 monthly visits). They will be able to be on the study medication free of charge (the study will pay for medication). Suvorexant Flyer